Advertisement
Research Article Free access | 10.1172/JCI119539
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Muraro, P. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Vergelli, M. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Kalbus, M. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Banks, D. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Nagle, J. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Tranquill, L. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Nepom, G. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Biddison, W. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by McFarland, H. in: JCI | PubMed | Google Scholar
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400, USA. pmuraro@box-p.nih.gov
Find articles by Martin, R. in: JCI | PubMed | Google Scholar
Published July 15, 1997 - More info
The pathogenesis of multiple sclerosis (MS) is currently ascribed in part to a T cell-mediated process targeting myelin components. The T cell response to one candidate autoantigen, myelin basic protein (MBP), in the context of HLA-DR15Dw2, has been previously studied in detail. However, the characteristics of cellular immunity in the context of other MS-associated HLA-DR haplotypes are scarcely known. MBP-specific T cell lines (TCL) were generated from HLA-DR4 (B1*0401)-positive MS subjects. Out of 275 MBP-specific TCL, 178 (64. 7%) specifically recognized region MBP(111-129), predominantly in the context of DRB1*0401. The major T cell epitope for MBP recognition corresponded to residues MBP(116-123). These TCL expressed disparate profiles of cytokine secretion and cytotoxicity. T cell receptor analysis, on the other hand, revealed a strikingly limited heterogeneity of rearrangements. In contrast to MBP(81-99), which binds with high affinity to HLA-DR15 and is recognized by a diverse T cell repertoire, MBP(111-129) binds weakly to DRB1*0401, suggesting that only high affinity T cell receptors might be able to efficiently engage such unstable MHC/peptide complexes, thus accounting for the T cell receptor restriction we observed. This study provides new insight about MBP recognition and proposes an alternative mechanism for immunodominance of self-antigen T cell epitopes in humans.